Actinium Pharmaceuticals
25,697
$0.31999876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.3199
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.016 (-4.85%) Today
+$0.0059 (+1.88%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell ATNM and other stocks, options, ETFs, and crypto commission-free!
About ATNM
Actinium Pharmaceuticals, Inc, also called Actinium Pharmaceuticals, is a biopharmaceutical company. It is focused on developing Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation. Read More Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.
CEO
Employees
25
Headquarters
New York, New York
Founded
1993
Market Cap
95.25M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
17.21M
High Today
$0.3339
Low Today
$0.3077
Open Price
$0.3314
Volume
9.88M
52 Week High
$0.62
52 Week Low
$0.157
Collections
ATNM Earnings
-$0.06
-$0.04
-$0.02
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 7, After Hours